Region:
Europe
Category:
Society

Coronavirus: Oxford vaccine still could be approved by Christmas, says AstraZeneca boss

  • Coronavirus: Oxford vaccine still could be approved by Christmas, says AstraZeneca boss
    The British company suspended late-stage trials this week after an illness in a participant in Britain. Coronavirus: Oxford vaccine still could be approved by Christmas, says AstraZeneca boss
Region:
Europe
Category:
Society
Publication date:
Print article

AstraZeneca should still know by year-end whether its experimental vaccine protects people against coronavirus, as long as it is cleared to resume trials soon, its chief executive said on Thursday amid doubts over its rollout.

The British company suspended late-stage trials this week after an illness in a participant in Britain. The patient was reportedly suffering from symptoms associated with a rare spinal inflammatory disorder called transverse myelitis.

Soriot said during an online event that AstraZeneca did not yet know the diagnosis, adding that it was not clear if the volunteer had transverse myelitis and more tests were needed.

He said the diagnosis would be submitted to an independent safety committee and this would usually then tell the company whether trials can be resumed.

Soriot said that the potential vaccine, which the World Health Organization (WHO) has flagged as the most promising for coronavirus, that it was usual for a trial to be suspended.

"It's very common, actually, and many experts will tell you this," Soriot said, adding: "The difference with other vaccine trials is, the whole world is not watching them, of course. They stop, they study, and they restart . "